Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Preparation process of transition metal boride and uses thereof
Method and system for calibrating laser profiling systems
Electrode composition with enhanced performance characteristics
Continuously variable transmission and control method thereof
Real-time virtual endoscopy
Decrementing settings for a range of power caps when a power cap is exceeded
  Randomly Featured Patents
Biphenylmethane derivative and pharmacological use
Golf ball
Method for checking beam generation and beam acceleration means of an ion beam therapy system
Process and device for centering a guide mandrel
Printer paper guide
Carcase, favorably furniture-carcase
Targeting system
Pharmaceutically active aza-bicyclo-benzamide derivatives
Method, apparatus and computer program product for discovering and prioritizing patterns of component usage in a virtual application container for enhancing prefetching
Process for producing high octane gasoline